Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:19 PM
Ignite Modification Date:
2025-12-24 @ 10:19 PM
NCT ID:
NCT03415035
Eligibility Criteria:
Inclusion Criteria:
* Participants with diagnosed Chronic Lymphocytic Leukemia (CLL) and eligible for venetoclax as per label.
* Participants for whom the physician has decided to initiate CLL treatment with venetoclax.
* Participants the physician believes he can personally follow over all the study period.
* Participants who have been informed verbally and in writing about this study, and who do not object to their data being electronically processed or subjected to data quality control.
Exclusion Criteria:
\- Participating in a clinical trial with an investigative drug for CLL within 30 days prior to treatment initiation.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT03415035
Study Brief:
Protocol Section:
NCT03415035